John N Gitonga
Overview
Explore the profile of John N Gitonga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimathi D, Juan-Giner A, Bob N, Orindi B, Namulwana M, Diatta A, et al.
N Engl J Med
. 2025 Feb;
392(8):788-797.
PMID: 39970397
Background: Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain unknown. Methods: In this double-blind, randomized, noninferiority...
2.
Kimotho J, Sein Y, Sayed S, Shah R, Mwai K, Saleh M, et al.
Wellcome Open Res
. 2024 Dec;
8:350.
PMID: 39640868
Background: Given the low levels of coronavirus disease 2019 (COVID-19) vaccine coverage in sub-Saharan Africa (sSA), despite high levels of natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) exposures, strategies for...
3.
Hamaluba M, Sang S, Orindi B, Njau I, Karanja H, Kamau N, et al.
Wellcome Open Res
. 2024 May;
8:182.
PMID: 38707489
Background: There are limited data on the immunogenicity of coronavirus disease 2019 (COVID-19) vaccines in African populations. Here we report the immunogenicity and safety of the ChAdOx1 nCoV-19 (AZD1222) vaccine...
4.
Jenkin D, Wright D, Folegatti P, Platt A, Poulton I, Alison Lawrie , et al.
Lancet Infect Dis
. 2023 Apr;
23(8):956-964.
PMID: 37060917
Background: Rift Valley fever is a viral epidemic illness prevalent in Africa that can be fatal or result in debilitating sequelae in humans. No vaccines are available for human use....
5.
Nyagwange J, Kutima B, Mwai K, Karanja H, Gitonga J, Mugo D, et al.
Int J Infect Dis
. 2022 Dec;
127:11-16.
PMID: 36476349
Objectives: Many regions of Africa have experienced lower COVID-19 morbidity and mortality than Europe. Pre-existing humoral responses to endemic human coronaviruses (HCoV) may cross-protect against SARS-CoV-2. We investigated the neutralizing...
6.
Lucinde R, Mugo D, Bottomley C, Karani A, Gardiner E, Aziza R, et al.
PLoS One
. 2022 Oct;
17(10):e0265478.
PMID: 36240176
Introduction: The high proportion of SARS-CoV-2 infections that have remained undetected presents a challenge to tracking the progress of the pandemic and estimating the extent of population immunity. Methods: We...
7.
Nyamwaya D, Otiende M, Mwango L, Kariuki S, Otieno B, Omuoyo D, et al.
PLoS Med
. 2022 May;
19(5):e1003994.
PMID: 35550620
Background: Neurological complications due to chikungunya virus (CHIKV) infection have been described in different parts of the world, with children being disproportionately affected. However, the burden of CHIKV-associated neurological disease...
8.
Mohammed K, de Laurent Z, Omuoyo D, Lewa C, Gicheru E, Cheruiyot R, et al.
Wellcome Open Res
. 2022 Mar;
5:162.
PMID: 35330938
The COVID-19 pandemic relies on real-time polymerase chain reaction (qRT-PCR) for the detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), to facilitate roll-out of patient care and infection control...
9.
Nyagwange J, Kutima B, Mwai K, Karanja H, Gitonga J, Mugo D, et al.
J Clin Virol
. 2022 Jan;
146:105061.
PMID: 34973474
Many SARS-CoV-2 antibody detection assays have been developed but their differential performance is not well described. In this study we compared an in-house (KWTRP) ELISA which has been used extensively...
10.
Kagucia E, Gitonga J, Kalu C, Ochomo E, Ochieng B, Kuya N, et al.
Open Forum Infect Dis
. 2021 Oct;
8(7):ofab314.
PMID: 34660838
In October 2020, anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) G seroprevalence among truck drivers and their assistants (TDA) in Kenya was 42.3%, higher than among healthcare workers and blood...